Last update:

Allergy and immunology news

Gut 'primes' pathogenic T cells responsible for neuroinflammation in multiple sclerosis, study finds

Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS). What makes the body turn against itself? ...

Vitamin D supplements may shift immune responses to gut bacteria in IBD

Vitamin D supplementation may help shape how the immune system responds to gut bacteria in people with inflammatory bowel disease (IBD), according to a Mayo Clinic-led study published in Cell Reports Medicine.

Living with dogs: Examining asthma outcomes in children

Living with a dog does not seem to worsen long-term asthma severity in children with allergic asthma, but may increase the risk of asthma exacerbations slightly, according to a study from Karolinska Institutet in Sweden that ...

Existing medication can restore HIV-affected immune cells

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing medication restores immune ...

Dual immune response may keep HIV in check without medication

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and ...

Skin's immune response could be key to fighting dengue

Dengue, a mosquito-borne viral disease, infects an estimated 390 million people and causes around 20,000 deaths worldwide each year. New research suggests the skin is a major site of immune surveillance for dengue. The findings ...

Key lung immune cells can intensify allergic reactions

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act as guardians, keeping the lungs healthy, supporting breathing, and preventing unnecessary immune ...

Engineered dendritic cells boost cancer immunotherapy

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.

FDA approves Waskyra for Wiskott-Aldrich syndrome

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).